Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliette Hommell-Fontaine

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Virchows Archiv : an International Journal of Pathology|April 24, 2010
Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinomaJuliette Hommell-Fontaine, Angela Borda, Florence Ragage, et al.
Virchows Archiv : an International Journal of Pathology|May 16, 2022
5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsiesZiyad Alsugair, Vahan Kepenekian, Tanguy Fenouil, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2011
Primary malignant solid pseudopapillary tumors of the gastroduodenal areaThomas Walter, Juliette Hommell-Fontaine, Valérie Hervieu, et al.
Neuroendocrinology|June 17, 2011
Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo propertiesThomas Walter, Juliette Hommell-Fontaine, Géraldine Gouysse, et al.
Virchows Archiv : an International Journal of Pathology|June 25, 2021
Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective studyNazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian, et al.
Virchows Archiv : an International Journal of Pathology|April 15, 2021
Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosisNazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian, et al.
Annales De Pathologie|March 18, 2014
[Peritoneal malignant mesothelioma: review and recent data]Éliane Mery, Juliette Hommell-Fontaine, Mathieu Capovilla, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Virchows Archiv : an International Journal of Pathology|April 24, 2010
Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinomaJuliette Hommell-Fontaine, Angela Borda, Florence Ragage, et al.
Virchows Archiv : an International Journal of Pathology|May 16, 2022
5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsiesZiyad Alsugair, Vahan Kepenekian, Tanguy Fenouil, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2011
Primary malignant solid pseudopapillary tumors of the gastroduodenal areaThomas Walter, Juliette Hommell-Fontaine, Valérie Hervieu, et al.
Neuroendocrinology|June 17, 2011
Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo propertiesThomas Walter, Juliette Hommell-Fontaine, Géraldine Gouysse, et al.
Virchows Archiv : an International Journal of Pathology|June 25, 2021
Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective studyNazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian, et al.
Virchows Archiv : an International Journal of Pathology|April 15, 2021
Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosisNazim Benzerdjeb, Peggy Dartigues, Vahan Kepenekian, et al.
Annales De Pathologie|March 18, 2014
[Peritoneal malignant mesothelioma: review and recent data]Éliane Mery, Juliette Hommell-Fontaine, Mathieu Capovilla, et al.
Pageof 1